Cronex.Co.,Ltd (XKON: 215570)
South Korea flag South Korea · Delayed Price · Currency is KRW
435.00
-35.00 (-7.45%)
Nov 15, 2024, 2:45 PM KST

Cronex.Co.,Ltd Company Description

Cronex.Co.,Ltd engages in the research and development of medicines and raw materials for medical research.

The company offers contract research organization services for dental materials, various implant materials, bone marrow restorations, and bone regeneration, skin penetration, high-frequency therapy device, patch drug test, biological dressing material, wound dressing, franz diffusion test skin; spinal implant efficacy evaluation, bone defect bone graft material efficacy evaluation, cartilage regeneration efficacy evaluation, X-ray, micro-CT, and histology; drug effectiveness evaluation experiments for new drug development using minipigs, beagle dogs, and rabbits; preclinical efficacy evaluation using medium-sized animals; and test progress, animal management, animal anesthesia, post-test management of animals, sampling, and test evaluation services.

It also provides medical collagens and disease testing services; and engages in research on a transgenic pig model using gene editing technology and somatic cell nuclear transfer technology to overexpress foreign genes or remove existing genes.

The company was incorporated in 2012 and is based in Seoul, South Korea.

Cronex.Co.,Ltd
Country South Korea
Founded 2012
Industry Commercial Physical and Biological Research
CEO Young-Joon Son

Contact Details

Address:
JNK Digital Tower
Seoul
South Korea
Phone 82 70 5214 1998
Website cronex.co.kr

Stock Details

Ticker Symbol 215570
Exchange Korea New Exchange
Reporting Currency KRW
SIC Code 8731

Key Executives

Name Position
Young-Joon Son Chief Executive Officer